1. Home
  2. TSBX vs EVGN Comparison

TSBX vs EVGN Comparison

Compare TSBX & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • EVGN
  • Stock Information
  • Founded
  • TSBX 2015
  • EVGN 1999
  • Country
  • TSBX United States
  • EVGN Israel
  • Employees
  • TSBX N/A
  • EVGN 75
  • Industry
  • TSBX
  • EVGN Agricultural Chemicals
  • Sector
  • TSBX
  • EVGN Industrials
  • Exchange
  • TSBX Nasdaq
  • EVGN Nasdaq
  • Market Cap
  • TSBX 7.7M
  • EVGN 11.3M
  • IPO Year
  • TSBX 2023
  • EVGN N/A
  • Fundamental
  • Price
  • TSBX $0.37
  • EVGN $1.33
  • Analyst Decision
  • TSBX Buy
  • EVGN Strong Buy
  • Analyst Count
  • TSBX 3
  • EVGN 1
  • Target Price
  • TSBX $4.75
  • EVGN $3.50
  • AVG Volume (30 Days)
  • TSBX 481.7K
  • EVGN 5.5M
  • Earning Date
  • TSBX 08-13-2025
  • EVGN 08-21-2025
  • Dividend Yield
  • TSBX N/A
  • EVGN N/A
  • EPS Growth
  • TSBX N/A
  • EVGN N/A
  • EPS
  • TSBX N/A
  • EVGN N/A
  • Revenue
  • TSBX N/A
  • EVGN $6,765,000.00
  • Revenue This Year
  • TSBX N/A
  • EVGN N/A
  • Revenue Next Year
  • TSBX N/A
  • EVGN $113.18
  • P/E Ratio
  • TSBX N/A
  • EVGN N/A
  • Revenue Growth
  • TSBX N/A
  • EVGN N/A
  • 52 Week Low
  • TSBX $0.29
  • EVGN $0.95
  • 52 Week High
  • TSBX $2.69
  • EVGN $6.80
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 52.32
  • EVGN 49.73
  • Support Level
  • TSBX $0.33
  • EVGN $1.26
  • Resistance Level
  • TSBX $0.37
  • EVGN $1.44
  • Average True Range (ATR)
  • TSBX 0.03
  • EVGN 0.11
  • MACD
  • TSBX -0.00
  • EVGN -0.02
  • Stochastic Oscillator
  • TSBX 53.33
  • EVGN 21.62

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: